4//SEC Filing
BIOGEN INC. 4
Accession 0001127602-16-040238
$BIIBCIK 0000875045operating
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 4:48 PM ET
Size
12.9 KB
Accession
0001127602-16-040238
Insider Transaction Report
Form 4
BIOGEN INC.BIIB
Holtzman Steven H
EVP Corp Devel and Strategy
Transactions
- Exercise/Conversion
Restricted Stock Unit
2016-02-08−2,709→ 0 totalExercise: $0.00Exp: 2016-02-08→ Common Stock (2,709 underlying) - Tax Payment
Common Stock
2016-02-08$250.77/sh−890$223,185→ 6,140 total - Exercise/Conversion
Common Stock
2016-02-08+2,709→ 7,030 total
Footnotes (1)
- [F1]The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 150% of the number of shares at target payout. One-fourth of these RSUs are eligible to vest on each of the first four anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen Idec common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the average 60 calendar-day closing stock price ending on the vesting date divided by the average 60 calendar-day closing stock price on the grant date]).
Issuer
BIOGEN INC.
CIK 0000875045
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000875045
Filing Metadata
- Form type
- 4
- Filed
- Feb 8, 7:00 PM ET
- Accepted
- Feb 9, 4:48 PM ET
- Size
- 12.9 KB